Tumor and Endothelial Cell Hybrids Participate in Glioblastoma Vasculature

Tumor and Endothelial Cell Hybrids Participate in Glioblastoma Vasculature

Background. Recently antiangiogenic therapy with bevacizumab has shown a high but transient efficacy in glioblastoma (GBM). Indeed, GBM is one of the most angiogenic human tumors and endothelial proliferation is a hallmark of the disease. We therefore hypothesized that tumor cells may participate i...

Full description

Bibliographic Details
Main Authors: El Hallani, Soufiane, Colin, Carole, El Houfi, Younas, Idbaih, Ahmed, Boisselier, Blandine, Marie, Yannick, Ravassard, Philippe, Labussière, Marianne, Mokhtari, Karima, Thomas, Jean-Léon, Delattre, Jean-Yves, Eichmann, Anne, Sanson, Marc
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017715/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017715/

Similar Items